The guidance was updated for clarity and to be more unambiguous regarding the recommendation to continue these medications and to not cease them prior to the procedure
A typical example was reported by Cecchini et al., demonstrating that PLGA polymers conjugated with different targeting peptides could be used for enzyme therapy of brain disorders such as Krabbe disease (Fig
Sandra Christensen: Preserving Muscle During GLP-1 Treatment | Ep
As a result, the same intensity of tACS can produce significantly varying electric field strengths in the cerebral cortex of different individuals
It will be critical for brands, retailers, and foodservice providers to keep a consistent pulse on the shifting purchasing dynamics and health-driven trade-offs, as consumers adopt, lapse, and return to these medications. Numerators GLP-1 Trends Hub coverage includes: State of GLP-1 Adoption : Tracks adoption trajectory and consumer sentiment across demographics, medications used, and related factors